Three cases of difficulty in achieving definitive loss of consciousness with remimazolam
Sign Up to like & getrecommendations! Published in 2022 at "JA Clinical Reports"
DOI: 10.1186/s40981-021-00485-1
Abstract: Background Remimazolam is a novel, ultra-short-acting benzodiazepine used for general anesthesia. Because remimazolam is an emerging drug, the tolerance to remimazolam in benzodiazepine-taking patients has been unclear. Also, the efficacy of remimazolam in different races… read more here.
Keywords: three cases; definitive loss; cases difficulty; difficulty achieving ... See more keywords